| Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS) (NCT00099463) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-12-09 |
| Collection of Data and Samples From Healthy Donors for Use in Translational Research (NCT00090662) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-12-09 |
| Doxycycline to Treat Mansonella Perstans Infection in Patients With and Without Lymphatic Filariasis (NCT00340691) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-12-06 |
| A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis (NCT00317330) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-12-01 |
| Fluarix Immunogenicity and Safety Trial (NCT00100399) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-12-01 |
| Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People (NCT00100633) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-12-01 |
| Mass Treatment T Solium Community Study (NCT00138359) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-12-01 |
| Influenza Vaccine in Pediatric Transplant Subjects (NCT00133510) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-11-01 |
| Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients (NCT00089466) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-11-01 |
| Voluntary HIV Counseling, Testing, and Medication for Pregnant Women to Prevent Mother-to-Child HIV Transmission (NCT00084045) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-11-01 |
| FLU-VACS Comparative Study in Adults (NCT00133523) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-10-01 |
| HIV Assessment in Fuyang, Anhui Province, China (NCT00094354) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-10-01 |
| Inactivated Influenza Vaccine in Infants 10-22 Weeks of Age (NCT00231920) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-10-01 |
| Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis (NCT00078247) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-10-01 |
| Caspofungin Study for Fungal Infections in Adults in Critical Care Settings (NCT00095316) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-10-01 |
| Intervention for Male STDs in India (NCT00170534) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-10-01 |
| Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant (NCT00092937) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-09-23 |
| Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults (NCT00083603) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-09-01 |
| Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults (NCT00089908) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-09-01 |
| RSV Challenge in Healthy Adults (NCT00100373) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-09-01 |
| Acute Viral Respiratory Infections in Elderly (NCT00170495) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-09-01 |
| Genetic Risk Factors for Severe Asthma (NCT00090740) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-09-01 |
| Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077) (NCT00094380) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-09-01 |
| Candidate HIV Vaccine (NCT00089531) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-08-02 |
| New Challenge Pool of Norwalk Virus Inoculum (NCT00138476) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-08-01 |
| Evaluation of an Asthma Treatment Strategy Based on Exhaled Nitric Oxide Measurements in Adolescents (NCT00114413) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-08-01 |
| Epi Cystic Hydatid Disease Peru (NCT00138346) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-08-01 |
| Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma (NCT00307177) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-08-01 |
| Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV) (NCT00078403) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-07-01 |
| Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda (NCT00639938) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-07-01 |
| Collection of Specimens for Study of Inflammatory Bowel Disease (NCT00086554) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-07-01 |
| Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV (NCT00086359) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-07-01 |
| Rapid HIV Testing for Emergency Department Patients (NCT00676481) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-07-01 |
| Atazanavir/Ritonavir Maintenance Therapy (NCT00084019) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-07-01 |
| Blood Levels of Abacavir in HIV Infected Adolescents (NCT00087945) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-07-01 |
| Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents (NCT00075907) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-07-01 |
| Experimental Vaccine for Plasmodium Falciparum Malaria (NCT00340431) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-06-09 |
| Omalizumab to Treat Eosinophilic Gastroenteritis (NCT00084097) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-06-02 |
| Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected Patients (NCT00085917) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-06-01 |
| Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines (NCT00138255) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-06-01 |
| An Interventional Study of Milk Allergy (NCT00578656) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-06-01 |
| Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients (NCT00080106) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-06-01 |
| Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers (NCT00083330) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-05-18 |
| Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients (NCT00082498) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-05-01 |
| Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients (NCT00001131) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-05-01 |
| Combination Study With MVA BN and Dryvax (NCT00082446) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-05-01 |
| Study of Tolerant Kidney Transplant Recipients (NCT01338779) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-05-01 |
| Experimental Vaccine for Malaria in Adults in Mali (NCT00343005) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-04-23 |
| Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults (NCT00061243) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-04-01 |
| Directly Observed Therapy in HIV Infected Adolescent Focus Groups (NCT00079729) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-04-01 |
| Dryvax Dilution-Prev Vacc Adults (NCT00032708) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-04-01 |
| Anti-CD20 Antibody Therapy for Sjogren's Syndrome (NCT00101829) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-04-01 |
| Comparing Allergenic Effects of 3 German Cockroach Extracts in Adults (NCT00132847) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-04-01 |
| Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP (NCT00076037) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-04-01 |
| Daclizumab to Treat HIV-Infected Patients (NCT00080431) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-03-26 |
| Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation (NCT00141037) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-03-01 |
| Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants (NCT00076791) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-03-01 |
| A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV Vaccines (NCT00076063) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-03-01 |
| Exhaled Breath Condensate as a Measure of Airway Inflammation in Children With Asthma (NCT00078208) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-02-18 |
| Papua New Guinean Duffy Negativity And Vivax Malar (NCT00138489) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-02-10 |
| Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis (NCT00396084) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-02-10 |
| Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in HIV (NCT00084149) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-02-01 |
| Leukapheresis for Research on HCV-Coinfected Patients (NCT00076427) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-01-14 |
| Epidemiological Study of HIV in the South African National Defense Force (NCT00341887) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-01-14 |
| Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents (NCT00073424) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-01-01 |
| GW873140 to Treat HIV-1 Infected Adults (NCT00076284) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-01-01 |
| An Observational Study of People Who Have Recently Been Infected With HIV (NCT00103961) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-01-01 |
| Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected Adults (NCT00069030) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-12-01 |
| Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies (NCT00311688) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-12-01 |
| Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults (NCT00071851) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-12-01 |
| Evaluation and Treatment of Severe Acute Respiratory Syndrome (SARS) (NCT00073086) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-11-05 |
| Methods of Determining Asthma Severity in Children (NCT00132834) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-11-01 |
| Experimental Ebola Vaccine Trial (NCT00072605) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-10-30 |
| Immune Responses to Mycobacterium Tuberculosis (NCT00340990) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-10-06 |
| An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies (NCT00072592) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-10-01 |
| Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults (NCT00051831) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-10-01 |
| Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx (NCT00071890) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-10-01 |
| An Electronic Pillbox for People With HIV (NCT00071500) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-10-01 |
| A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth (NCT00069004) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-10-01 |
| Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies (NCT00067054) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-09-10 |
| VRC 300: Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious Diseases (NCT00068926) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-09-03 |
| IVIG - West Nile Encephalitis: Safety and Efficacy (NCT00068055) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-09-01 |
| Novel Protective Underglove (NCT00170586) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-09-01 |
| Immune Response to Influenza Vaccine in HIV-Infected Individuals (NCT00069914) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-09-01 |
| West Nile Virus Natural History (NCT00138463) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-09-01 |
| Investigating Severe Acute Respiratory Syndrome (SARS) (NCT00066209) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-08-04 |
| Safety of the EnvPro HIV Vaccine in Healthy Volunteers (NCT00076947) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-08-01 |
| Chiron Corp HCV E1/E2 Vaccine (NCT00500747) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-08-01 |
| Research for Elim of Filariasis (NCT00145223) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-08-01 |
| Anthrax-rPA: Safety, Tolerability, Immunogenicity (NCT00063843) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-07-01 |
| Long-term Follow-up of HIV Infected Patients Identified During Early Infection (NCT00086372) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-07-01 |
| Dressing Preparations for Smallpox (NCT00063856) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-07-01 |
| Antiviral Therapy and HIV in the Female Genital Tract (NCT00067106) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-07-01 |
| Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome (NCT00065390) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-07-01 |
| Prevention of GBS Colonization Via Immunity (NCT00128219) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-07-01 |
| Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy (NCT00042289) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-06-09 |
| Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure (NCT00062621) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-06-01 |
| Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant (NCT00063817) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-06-01 |
| Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10% (NCT00090194) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-06-01 |
| Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor (NCT00095329) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-05-01 |